Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials

Journal of Inherited Metabolic Disease

Volumn 34, Issue 1, 2011, Pages 83-91

  Clarke, Robert ^a   Halsey, Jim ^a   Bennett, Derrick ^a   Lewington, Sarah ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE; VITAMIN B COMPLEX;

CARDIOVASCULAR RISK; HUMAN; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STROKE; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DOWN REGULATION; META ANALYSIS; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; VASCULAR DISEASE;

CAUSE OF DEATH; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DOWN-REGULATION; FOLIC ACID; HOMOCYSTEINE; HUMANS; NEOPLASMS; VASCULAR DISEASES; VITAMIN B COMPLEX;

EID: 79955862230     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9235-y     Document Type: Review

References (38)

1. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E et al (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 299(17):2027-2036 (Pubitemid 351656584)
2. Baker F, Picton D, Blackwood S, Hunt J, Erskine M, Dyas M et al (2002) Blinded comparison of folic acid and placebo in patients with ischaemic heart disease: an outcome trial. Circulation 106:3642, abst
3. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K, NORVIT Trial Investigators (2006) Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. N Engl J Med 354(15):1578-1588
4. Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS et al (2009) Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis 53(1):121-128
5. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274(13):1049-1057
6. B-Vitamin Treatment Trialists' Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151(2):282-287
7. Carson NA, Cusworth DC, Dent CE, Field CM, Neill DW, Westall RG (1963) Homocystinuria: a new inborn error of metabolism associated with mental deficiency. Arch Dis Child 38:425-436
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324(17):1149-1155
9. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE et al (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer and cause-specific mortality: meta-analysis of 8 randomized trials involving 37485 individuals. Arch Int Med 170:1622-1630
10. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS et al (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297(21):2351-2359 (Pubitemid 46883748)
11. Danesh J, Lewington S (1998) Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 5(4):229-232 (Pubitemid 29030108)
12. Early Breast Cancer Trialists' (CTT) Collaborative Group (1990) Treatment of early breast cancer. Vol 1 Worldwide evidence 1985-1990. Oxford University Press, Oxford
13. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE et al (2008) Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 300(7):795-804
14. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS et al (2009) Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 101(6):432-435
15. Galan P, Briancon S, Blacher J, Czernichow S, Hercberg S (2008) The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics. Trials 9:35
16. Gerritsen T, Vaughn JG, Waisman HA (1962) The identification of homocystine in the urine. Biochem Biophys Res Commun 9:493-496
17. Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132(8 Suppl):2350S-2355S
18. Hankey GJ, Algra A, Chen C, Wong MC, Cheung R, Wong L et al (2007) VITATOPS, the Vitamins to prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke. Int J Stroke 2(2):144-150 (Pubitemid 46691714)
19. Homocysteine Lowering Trialists' Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82(4):806-812
20. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke a meta-analysis. JAMA 288:2015-2022
21. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD et al (2007) Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 298(10):1163-1170 (Pubitemid 47403102)
22. Kim YI (2004) Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 80(5):1123-1128
23. Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99(1):64-76
24. Lin J, Lee IM, Cook NR, Selhub J, Manson JE, Buring JE et al (2008) Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 87(3):734-743 (Pubitemid 351364556)
25. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, Sheridan P, Pogue J et al (2006) Homocysteine lowering with folic acid and B-vitamins in vascular disease. N Engl J Med 354:1567-1577
26. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G et al (2007) A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomark Prev 16(7):1325-1329 (Pubitemid 47076861)
27. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56(1):111-128
28. Mudd SH, Finkelstein JD, Irreverre F, Laster L (1964) Homocystinuria: an enzymatic defect. Science 143:1443-1445
29. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R et al (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1-31 (Pubitemid 15138674)
30. Mudd SH, Levy HL, Skovby F (1989) Disorders of transulfuration. In: Schriver CF, Baudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw Hill, New York, pp 693-734
31. Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH) Collaborative Group (2010) Effects of homocysteine- lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 303:2486-2494
32. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291(5):565-575 (Pubitemid 38500310)
33. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Yet al (2007) Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369(9576):1876-1882 (Pubitemid 46829358)
34. Wilcken DEL, Wilcken B (1976) The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 57:1079-1082
35. Yang Q, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H et al (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113(10):1335-1343 (Pubitemid 43739455)
36. Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ et al (2001) Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol 21(12):2080-2085 (Pubitemid 34219765)
37. Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH (1985) Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 6(7):556-585 (Pubitemid 15046383)
38. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD et al (2003) Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 95(5):373-380 (Pubitemid 36395257)